News | RIVM

Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity

This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Plant Protection Products: new RIVM methodology calculates period in which workers must wear gloves

Commissioned by the Dutch Ministry of Social Affairs and Employment (SZW), RIVM has developed a new methodology to calculate the period for which workers must wear gloves to mitigate the risk of re

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

Protection of Defence personnel against health risks of chromium-6 was inadequate

From 1984-2006, employees of the Dutch Ministry of Defence were exposed to chromium-6 during maintenance work.

RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

The National Immunisation Programme in the Netherlands 2013 - 2014

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).